Showing results (1-10 of 144) with videos related to
Sort By:
Pageof 15
Cancer Discovery|September 3, 2017
Fast-TRKing Drug Development for Rare Molecular TargetsAparna R Parikh, Ryan B CorcoranJournal of Gastrointestinal Oncology|December 24, 2015
New therapeutic strategies for BRAF mutant colorectal cancersRyan B CorcoranHematology/Oncology Clinics of North America|May 16, 2022
Evolving Role of Circulating Tumor DNA and Emerging Targeted Therapy in Colorectal CancerMidhun Malla, Aparna R ParikhJournal of the National Comprehensive Cancer Network : JNCCN|December 16, 2024
ctDNA/MRD Testing for Colon Cancer: A Work in Progress or Ready for Prime-Time Standard of Care?Bennett A Caughey, Aparna R ParikhCancer Discovery|February 17, 2019
Targeting Alterations in the RAF-MEK PathwayRona Yaeger, Ryan B CorcoranCancer Discovery|October 4, 2018
Blood-Based Prediction of Tumor Relapse: The cfDNA ForecastGiulia Siravegna, Ryan B CorcoranProceedings of the National Academy of Sciences of the United States of America|May 19, 2006
Oxysterols stimulate Sonic hedgehog signal transduction and proliferation of medulloblastoma cellsRyan B Corcoran, Matthew P ScottNature Reviews. Clinical Oncology|October 3, 2018
Therapeutic strategies to target RAS-mutant cancersMeagan B Ryan, Ryan B CorcoranGenome Medicine|April 23, 2017
Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapyLeanne G Ahronian, Ryan B CorcoranMolecular & Cellular Oncology|June 17, 2016
Effective MAPK Inhibition is critical for therapeutic responses in colorectal cancer with BRAF mutationsLeanne G Ahronian, Ryan B CorcoranPageof 15